CAS NO: | 1800025-30-2 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | TP-020 (MGAT2-IN-1) is an orally active inhibitor of monoacylglycerolacyltransferase(MGAT2) withIC50of 7.8 and 2.4 nM for human and mouseMGAT2, respectively. | ||||||||||||||||
IC50& Target | IC50: 7.8 nM (Human MGAT2), 2.4 nM (Mouse MGAT2)[1] | ||||||||||||||||
体内研究 (In Vivo) | TP-020 (3, 10 mg/kg, p.o.) dose-dependently suppresses plasma TG elevation, and plasma CM/TG AUC in mice. TP-020 does not decrease MG absorption but inhibits MGAT2-dependent TG/DG resynthesis. In the lipid utilization analysis, TP-020 significantly increases free fatty acid (FFA) and acylcarnitine levels. TP-020 (30 mg/kg) also significantly reduces food intake dose dependently, suppresses BW gains. TP-020 shows anti-diabetic effects in mice[1]. | ||||||||||||||||
分子量 | 654.01 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C27H21ClF5N7O3S | ||||||||||||||||
CAS 号 | 1800025-30-2 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 125 mg/mL(191.13 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |